What is the recommended melatonin dose for adults, older adults, children, and for jet lag?

Melatonin Dosing Recommendations

Melatonin should NOT be used for chronic insomnia in adults, but IS recommended for circadian rhythm disorders (delayed sleep-wake phase disorder) and jet lag, with specific dosing varying by indication and age group.

Adults with Chronic Insomnia

The American Academy of Sleep Medicine explicitly recommends AGAINST using melatonin for sleep onset or sleep maintenance insomnia in adults 1. This is based on trials using 2 mg doses and reflects insufficient evidence for efficacy in primary insomnia. Instead, consider FDA-approved alternatives like ramelteon (melatonin receptor agonist at 8 mg), eszopiclone (2-3 mg), or zolpidem (10 mg) 1.

Adults with Delayed Sleep-Wake Phase Disorder (DSWPD)

For circadian rhythm disorders, melatonin has a role:

• Dose: 5 mg taken between 19:00-21:00 (7-9 PM) for 28 days 2
• Timing is critical: 1.5-2 hours before desired bedtime
• Evidence quality is LOW, but clinical acceptance is high 2

Critical caveat: Taking melatonin at the wrong time (early in the day) causes sleepiness and delays adaptation to local time 3.

Jet Lag

For eastward flights crossing 5+ time zones, melatonin is remarkably effective 3:

• Dose: 0.5-5 mg (both equally effective for jet lag, though 5 mg improves sleep quality more than 0.5 mg)
• Timing: 10 PM-midnight at destination (close to target bedtime)
• Take for several days after arrival
• Number needed to treat (NNT) = 2 3
• Avoid 2 mg slow-release formulations - they are less effective than immediate-release 4

The benefit is greater for more time zones crossed and less effective for westward flights 3.

Children and Adolescents with DSWPD

Without Comorbidities (ages 6-12):

• Dose: 0.15 mg/kg (optimal dose, approximately 4.4 mg mean) 2
• Timing: 1.5-2 hours before habitual bedtime
• Evidence quality: MODERATE 2
• Lower doses (0.05 mg/kg and 0.1 mg/kg) were less effective

With Psychiatric Comorbidities (e.g., ADHD):

• Dose: 3 mg if <40 kg; 5 mg if >40 kg 2
• Timing: 18:00-19:00 (6-7 PM)
• Use fast-release formulation
• Duration: 4 weeks
• Evidence quality: LOW 2

Important safety note: Long-term safety data in children are lacking, and concerns exist about developmental effects. Obtain informed consent from caregivers 2.

Older Adults (≥55 years)

For insomnia in older adults:

• Use the lowest possible dose of immediate-release melatonin to mimic physiological circadian rhythm 5
• Typical range: 1-6 mg 6
• Most effective in elderly with documented low endogenous melatonin levels or chronic benzodiazepine users 7
• Avoid supra-physiological doses that maintain prolonged elevated levels 5

Recent evidence suggests optimal timing is 1-2 hours before bedtime (around 6 PM), not 30 minutes before 8, 9. A 2024 dose-response meta-analysis found that 4 mg administered 3 hours before desired bedtime optimizes efficacy for reducing sleep onset latency 9.

Key Clinical Pitfalls

1. Wrong indication: Don't use melatonin for primary insomnia in adults - guideline evidence recommends against it 1

2. Wrong formulation: Avoid slow-release preparations for jet lag and most sleep disorders - immediate-release is more effective 3, 4

3. Wrong timing: Administration too close to bedtime (30 minutes) is less effective than 1.5-3 hours before 9

4. Quality control issues: In the U.S., melatonin is unregulated as a dietary supplement, with actual content varying widely from labeled doses 10, 11

5. Drug interactions: Use caution in patients on warfarin or with epilepsy 3

6. Dose escalation: Higher doses above 5 mg show no additional benefit for most indications 3, 4